Lakefront Biotherapeutics NV (LKFT): key financial figures for fiscal year 2025 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- €1.1B
- Net Income/Loss (FY2025)
- €320.9M
- Total Assets (FY2025)
- €3.4B
- Total Equity (FY2025)
- €3.2B
- Cash Flows from Operating Activities (FY2025)
- -€257.5M
Source: Lakefront Biotherapeutics NV 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
